Enovis Operating Margin 2010-2024 | ENOV
Enovis Operating Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Operating Income | Operating Margin |
2024-03-31 | $1.82B | $-0.08B | -4.13% |
2023-12-31 | $1.71B | $-0.07B | -3.81% |
2023-09-30 | $1.66B | $-0.09B | -5.23% |
2023-06-30 | $1.63B | $-0.09B | -5.22% |
2023-03-31 | $1.59B | $-0.07B | -4.08% |
2022-12-31 | $1.56B | $-0.07B | -4.54% |
2022-09-30 | $0.99B | $-0.14B | -14.31% |
2022-06-30 | $0.96B | $-0.14B | -14.46% |
2022-03-31 | $0.92B | $-0.16B | -16.81% |
2021-12-31 | $1.43B | $-0.06B | -4.42% |
2021-09-30 | $0.47B | $-0.14B | -28.54% |
2021-06-30 | $0.92B | $-0.06B | -6.20% |
2021-03-31 | $1.18B | $-0.05B | -4.40% |
2020-12-31 | $1.12B | $-0.07B | -5.89% |
2020-09-30 | $3.13B | $0.20B | 6.26% |
2020-06-30 | $3.17B | $0.20B | 6.37% |
2020-03-31 | $3.46B | $0.25B | 7.20% |
2019-12-31 | $3.33B | $0.20B | 6.13% |
2019-09-30 | $2.67B | $0.12B | 4.54% |
2019-06-30 | $2.34B | $0.09B | 3.75% |
2019-03-31 | $2.00B | $0.09B | 4.56% |
2018-12-31 | $2.19B | $0.15B | 6.89% |
2018-09-30 | $1.48B | $0.07B | 4.87% |
2018-06-30 | $1.80B | $0.11B | 6.23% |
2018-03-31 | $2.09B | $0.14B | 6.57% |
2017-12-31 | $1.94B | $0.14B | 6.97% |
2017-09-30 | $3.01B | $0.26B | 8.70% |
2017-06-30 | $2.93B | $0.25B | 8.38% |
2017-03-31 | $3.04B | $0.25B | 8.18% |
2016-12-31 | $3.19B | $0.24B | 7.44% |
2016-09-30 | $3.13B | $0.23B | 7.22% |
2016-06-30 | $3.33B | $0.21B | 6.39% |
2016-03-31 | $3.40B | $0.24B | 6.97% |
2015-12-31 | $3.43B | $0.27B | 7.75% |
2015-09-30 | $4.11B | $0.33B | 7.95% |
2015-06-30 | $4.31B | $0.40B | 9.29% |
2015-03-31 | $4.48B | $0.40B | 8.91% |
2014-12-31 | $4.62B | $0.41B | 8.87% |
2014-09-30 | $4.59B | $0.42B | 9.22% |
2014-06-30 | $4.44B | $0.41B | 9.17% |
2014-03-31 | $4.31B | $0.42B | 9.81% |
2013-12-31 | $4.21B | $0.41B | 9.67% |
2013-09-30 | $4.06B | $0.34B | 8.34% |
2013-06-30 | $4.00B | $0.29B | 7.20% |
2013-03-31 | $3.97B | $0.24B | 5.94% |
2012-12-31 | $3.91B | $0.14B | 3.58% |
2012-09-30 | $3.06B | $0.08B | 2.61% |
2012-06-30 | $2.28B | $0.03B | 1.45% |
2012-03-31 | $1.42B | $-0.01B | -0.70% |
2011-12-31 | $0.69B | $0.03B | 3.60% |
2011-09-30 | $0.68B | $0.05B | 7.76% |
2011-06-30 | $0.65B | $0.06B | 8.84% |
2011-03-31 | $0.58B | $0.05B | 7.75% |
2010-12-31 | $0.54B | $0.04B | 6.46% |
2010-09-30 | $0.51B | $0.03B | 4.94% |
2010-06-30 | $0.50B | $0.03B | 5.17% |
2010-03-31 | $0.51B | $0.03B | 5.70% |
2009-12-31 | $0.53B | $0.04B | 7.62% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.812B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
Axonics (AXNX) | United States | $3.433B | 0.00 |
10x Genomics (TXG) | United States | $3.275B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.194B | 0.00 |
Azenta (AZTA) | United States | $2.979B | 242.82 |
Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
Privia Health (PRVA) | United States | $2.224B | 98.63 |
Schrodinger (SDGR) | United States | $1.712B | 0.00 |
Omnicell (OMCL) | United States | $1.384B | 47.83 |
Phreesia (PHR) | United States | $1.259B | 0.00 |
Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
Standard BioTools (LAB) | United States | $0.728B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
Talkspace (TALK) | United States | $0.538B | 0.00 |
Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
Pulmonx (LUNG) | United States | $0.378B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
American Well (AMWL) | United States | $0.165B | 0.00 |
Outset Medical (OM) | United States | $0.162B | 0.00 |
Augmedix (AUGX) | United States | $0.133B | 0.00 |
MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
TruBridge (TBRG) | United States | $0.125B | 5.33 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
111 (YI) | China | $0.096B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
Zepp Health (ZEPP) | China | $0.053B | 0.00 |
Movano (MOVE) | United States | $0.046B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |